Leuprolide: all 151 studies that test it

Page 1 of 2. Open to participants first (17), then studies with results posted, then the rest; newest registration first within each.

• Phase Ia Trial of HHK001 Compared With Enantone in Patients With EndometriosisRecruitingNCT07755956Phase 1
• A Study of Leuprorelin 1-Month (4-Week) Formulation in Children With Central Precocious PubertyRecruitingNCT07710430Phase 4
• Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CTRecruitingNCT07455903Phase 2
• Rezvilutamide for High-Risk Prostate Cancer After SurgeryNot yet recruitingNCT07444983Not applicable
• Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS TrialRecruitingNCT07158021Phase 2
• REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac TrialRecruitingNCT06650579Phase 3
• A Study on the Efficacy of Androgen Deprivation Therapy Combined With Anti-PD-1 Therapy in Advanced Lung CancerRecruitingNCT06512207Not applicable
• Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate CancerRecruitingNCT06330805Phase 2
• Treatment of High-Risk Prostate Cancer Guided by Novel Diagnostic Radio- and Molecular TracersRecruitingNCT06282588Phase 2/3
• Evaluate the Efficacy and Safety of DWJ108JRecruitingNCT06025409Phase 3
• Adenomyosis and ARTRecruitingNCT05937490Phase 4
• Kisspeptin Administration Subcutaneously to Patients With IHHRecruitingNCT05896293Phase 2
• Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624RecruitingNCT05781217Phase 3
• A Multicenter Open-label Clinical Study on the Prevention of Premature Ovarian Failure After HSCTNot yet recruitingNCT05667428Not applicable
• A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver DiseaseRecruitingNCT05478083Phase 2
• Comparison of the Therapeutic Effects of Vaginal Repair With Leuprorelin and Vaginal Repair in the Treatment of Cesarean Section Scar DefectRecruitingNCT05206682Not applicable
• Impact of Hormonal Therapy on Prostate Cancer Recurrence After Radical ProstatectomyRecruitingNCT05169112Phase 3
• RElugolix VErsus LeUprolide Cardiac TrialActive, not recruitingNCT05320406Phase 2Results posted
• Pre-Exposure Prophylaxis (PrEP)- Gender Affirming Hormone Therapy (GAHT) Interactions in TGWCompletedNCT04760691Phase 1Results posted
• Neurobiology of Bulimia NervosaCompletedNCT04225221Phase 2Results posted
• Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine ModelCompletedNCT04051320Phase 2Results posted
• A Study to Evaluate Leuprolide Acetate 45 mg 6-Month Formulation in Children With Central Precocious Puberty (CPP)CompletedNCT03695237Phase 3Results posted
• Radium Ra 223 Dichloride, Hormone Therapy and Stereotactic Body Radiation Therapy in Treating Patients With Metastatic Prostate CancerActive, not recruitingNCT03361735Phase 2Results posted
• Systemic and Tumor-Directed Therapy for Oligometastatic Prostate CancerCompletedNCT03298087Phase 2Results posted
• Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate CancerCompletedNCT03261999Phase 3Results posted
• A Study of Definitive Therapy to Treat Prostate Cancer After ProstatectomyCompletedNCT03043807Phase 2Results posted
• A Study of ELIGARD® in Hormone-dependent Prostate Cancer PatientsCompletedNCT03035032Phase 4Results posted
• Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADTCompletedNCT03007732Phase 2Results posted
• Regulation of Cervical Mucus SecretionCompletedNCT02969590Phase 4Results posted
• Brown Adipose Tissue Activity in Pre- and Postmenopausal WomenCompletedNCT02927392Not applicableResults posted
• AASUR in High Risk Prostate CancerCompletedNCT02772588Phase 2Results posted
• Apalutamide and Leuprolide in Intermediate and High-risk Prostate CancerCompletedNCT02770391Phase 2Results posted
• A Study of Definitive Therapy to Treat Prostate CancerCompletedNCT02716974Phase 2Results posted
• Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate CancerTerminatedNCT02508636Phase 2Results posted
• Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious PubertyCompletedNCT02452931Phase 3Results posted
• A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese ParticipantsCompletedNCT02427958Phase 4Results posted
• Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate CarcinomaCompletedNCT02234115Phase 3Results posted
• Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in WomenCompletedNCT02122198Not applicableResults posted
• A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate CancerCompletedNCT02085252Phase 3Results posted
• Effects of Estrogen Deficiency on Energy ExpenditureCompletedNCT01846728Not applicableResults posted
• Neurophysiology of Postpartum Depression in an Experimental Model of Pregnancy and ParturitionCompletedNCT01762943Not applicableResults posted
• Bipolar Androgen-based Therapy for Prostate Cancer (BAT)CompletedNCT01750398Phase 2Results posted
• Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)CompletedNCT01642186Phase 2Results posted
• A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-naïve Patients With Premenopausal Breast CancerCompletedNCT01546649Phase 3Results posted
• A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal TherapyCompletedNCT01546623Phase 3Results posted
• Efficacy and Safety of Leuprolide Acetate 22.5 mg Depot in Treatment of Prostate CancerCompletedNCT01415960Phase 3Results posted
• Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow TransplantationCompletedNCT01338987Phase 2Results posted
• GnRH-a and Pregnancy Rate in In Vitro Fertilization (IVF) Cycles.CompletedNCT01269125Not applicableResults posted
• Randomized Crossover Trial to Assess the Tolerability of Gonadotropin Releasing Hormone (GnRH) Analogue AdministrationCompletedNCT01161563Phase 4Results posted
• Impact of Hot Flashes on Sleep and Mood DisturbanceCompletedNCT01116401Phase 4Results posted
• Neoadjuvant Hormones + Docetaxel in Node-Positive Prostate CancerCompletedNCT01076335Phase 2Results posted
• Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical ProstatectomyTerminatedNCT00937768Phase 2Results posted
• Safety Study of Sorafenib With Androgen Deprivation and Radiotherapy to Treat Prostate CancerTerminatedNCT00924807Phase 1/2Results posted
• A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate CancerCompletedNCT00924469Phase 2Results posted
• Extended Endocrine Therapy for Premenopausal Women With Breast CancerCompletedNCT00903162Phase 2Results posted
• Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate CancerTerminatedNCT00860158Phase 2Results posted
• Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious PubertyCompletedNCT00667446Phase 3Results posted
• Study of Lupron Depot In The Treatment of Central Precocious PubertyCompletedNCT00660010Phase 3Results posted
• A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious PubertyCompletedNCT00635817Phase 3Results posted
• A Study of Leuprolide to Treat Prostate CancerCompletedNCT00626431Phase 3Results posted
• Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVFCompletedNCT00621179Phase 4Results posted
• Hormone Therapy and Intensity-Modulated Radiation Therapy in Treating Patients With Metastatic Prostate CancerActive, not recruitingNCT00544830Phase 2Results posted
• Understanding Experimentally Induced Hot FlushesCompletedNCT00455689Phase 4Results posted
• A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation TherapyCompletedNCT00451958Phase 3Results posted
• GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation PatientsCompletedNCT00429494Phase 2Results posted
• External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate CancerTerminatedNCT00388804Phase 3Results posted
• Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short StatureCompletedNCT00355030Phase 3Results posted
• A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow TransplantationTerminatedNCT00275262Phase 2Results posted
• Melanoma Vaccine With Peptides and LeuprolideCompletedNCT00254397Phase 2Results posted
• Effects of IAS in Men With Localized Biochemical Relapsed Prostate CancerCompletedNCT00223665Phase 2Results posted
• Polycystic Ovary Syndrome (PCOS) and Sleep ApneaTerminatedNCT00203996Phase 4Results posted
• Insulin Resistance and Testosterone in WomenCompletedNCT00123110Phase 2Results posted
• Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for RecurrenceTerminatedNCT00003645Phase 3Results posted
• Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00002597Phase 3Results posted
• The Role of Hormones in Postpartum Mood DisordersCompletedNCT00001481Phase 2Results posted
• A Treatment Study for Premenstrual Syndrome (PMS)CompletedNCT00001259Phase 1Results posted
• The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart.CompletedNCT06984159Phase 3
• COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcerActive, not recruitingNCT06627530Phase 4
• Efficacy and Safety of DKF-MA102 in Patients With Prostate CancerCompletedNCT06490328Phase 3
• Bipolar Androgen Therapy to Restore Sensitivity to Androgen Deprivation Therapy for Patients With Metastatic Castration Resistant Prostate CancerActive, not recruitingNCT06305598Phase 1
• Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell TumorsActive, not recruitingNCT06169124Phase 2
• GnRH-a on Angiogenesis of EndometriosisCompletedNCT06106932Not applicable
• A Phase II Study of Advanced Salivary Gland Carcinoma Based on Molecular TypingActive, not recruitingNCT05924256Phase 2
• Testing the Anti-cancer Drug Darolutamide in Patients With Testosterone-Driven Salivary Gland CancersActive, not recruitingNCT05669664Phase 2
• A Neoadjuvant Study of Abiraterone Acetate, Leuprolide Acetate, and Belzutifan in Men With Regional Prostate CancerWithdrawnNCT05574712Phase 2
• Study to Evaluate the Safety and Efficacy of Switching From Zoladex® Monthly or Quarterly, to Eligard® Semiannual.CompletedNCT05304169Phase 4
• Enhanced Systemic Combined With Local Treatment for Primary and Metastatic Lesions in Oligo-metastatic Prostate CancerStatus unknownNCT05212857Phase 2
• Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialActive, not recruitingNCT05050084Phase 3
• Leuprolide Acetate 3.75 mg Depot Injection for Patients With Advanced Prostate CancerCompletedNCT04914195Phase 3
• The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1Status unknownNCT04840745Phase 1
• To Compare the Safety and Pharmacokinetics of PT105 With PT105R in Healthy Postmenopausal Female VolunteersStatus unknownNCT04783636Phase 1
• Role of Suppression of Endometriosis With Progestins Before IVF-ETCompletedNCT04500743Not applicable
• Bariatric Arterial Embolization for Men Starting Hormones for Prostate CancerWithdrawnNCT04331717Phase 2
• Androgen Deprivation Therapy for Oligo-recurrent Prostate Cancer in Addition to radioTherapyActive, not recruitingNCT04302454Phase 3
• Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsStatus unknownNCT04248621Phase 4
• A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate CancerActive, not recruitingNCT04194554Phase 1/2
• PREOPERATIVE GONADOTROPINE-RELEASING HORMONE AGONIST THERAPY BEFORE SURGERY FOR UTERİN FIBROIDSStatus unknownNCT04192812Not applicable
• Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate CancerActive, not recruitingNCT03902951Phase 2
• PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS RateActive, not recruitingNCT03900637Phase 2
• Comparison of a Novel Leuprolide With Market LeuprolideStatus unknownNCT03662958Not applicable

← Leuprolide overview